Logo-bi
Bioimpacts. 2020;10(4): 235-242. doi: 10.34172/bi.2020.30
PMID: 32983939        PMCID: PMC7502904

Original Research

Classification and identification of human papillomavirus based on its prevalence and development of cervical lesion among Iranian women

Mitra Moeinzadeh 1 ORCID, Babak Kheirkhah 2 * ORCID, Kumarss Amini 3 ORCID, Ali Pouryasin 4 ORCID

Cited by CrossRef: 7


1- Ortiz Segarra J, Vega Crespo B, Campoverde Cisneros A, Salazar Torres K, Delgado López D, Ortiz S. Human Papillomavirus Prevalence and Associated Factors in Indigenous Women in Ecuador: A Cross-Sectional Analytical Study. Infectious Disease Reports. 2023;15(3):267 [Crossref]
2- Sevostyanova O, Oboskalova T, Chumarnaya  , Rosyuk E, Belomestnov S, Sevostyanova N. Epidemiological features of the incidence of cervical intraepithelial neoplasia in the modern megapolis. Opuholi ženskoj reproduktivnoj sistemy. 2023;19(1):112 [Crossref]
3- Rosendo-Chalma P, Antonio-Véjar V, Ortiz Tejedor J, Ortiz Segarra J, Vega Crespo B, Bigoni-Ordóñez G. The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus. Biology. 2024;13(2):77 [Crossref]
4- Noori R, Salih A, Alhar H, Al Fatlawi S, Al-Janabi A, Hameed R. Prevalence and Genotype Distribution of HPV in Gynecological Patients: A Cross-Sectional Study. Indonesian J Clin Pathol Med Lab. 2024;31(1):7 [Crossref]
5- Peng P, Peng X, Jiao X, Chen N. A unique Levey–Jennings control chart used for internal quality control in human papillomavirus detection. Virol J. 2022;19(1) [Crossref]
6- Hasanzadeh M, Jamehdar S, Seresht L, Shakeri M, Bolandi S. Transitional Epidemiology of Human Papillomavirus Infection in Iran: A Cross-Sectional Study and National Review. 2023;12(1) [Crossref]
7- Shao Y, Shah P, Su Q, Li S, Huang F, Wang J, Wang P, Wu C. Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells. Front Cell Infect Microbiol. 2024;14 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge